Dr. Prithviraj Bose
Claim this profileM D Anderson Cancer Center
Studies Myelofibrosis
Studies Thrombocythemia
7 reported clinical trials
10 drugs studied
Area of expertise
1Myelofibrosis
JAK2 positive
Stage I
Stage II
2Thrombocythemia
JAK2 positive
Affiliated Hospitals
Clinical Trials Prithviraj Bose is currently running
Selinexor + Ruxolitinib
for Myelofibrosis
This is a global, multicenter, 2-part study to evaluate the efficacy and safety of selinexor plus ruxolitinib in JAK inhibitor (JAKi) treatment-naïve myelofibrosis (MF) participants. The study will be conducted in two phases: Phase 1 (open-label) and Phase 3 (double-blind). Phase 1 (enrollment completed) was an open-label evaluation of the safety and recommended Phase 2 dose (RP2D) of selinexor in combination with ruxolitinib and included a dose escalation using a standard 3+3 design (Phase 1a) and a dose expansion part (Phase 1b). Phase 3 (ongoing), double-blind, placebo-controlled part of the study comparing the efficacy and safety of combination therapy of selinexor + ruxolitinib with combination of placebo + ruxolitinib.
Recruiting1 award Phase 320 criteria
DISC-0974
for Myelofibrosis
This phase 1b/2a open-label study will assess the safety, tolerability, pharmacokinetics and pharmacodynamics of DISC-0974 as well as categorize the effects on anemia response in subjects with myelofibrosis or myelodysplastic syndrome and anemia.
Recruiting1 award Phase 1 & 2
More about Prithviraj Bose
Clinical Trial Related10 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Prithviraj Bose has experience with
- Ruxolitinib
- Elotuzumab
- CPI-0610
- Pelabresib (CPI-0610)
- Avapritinib
- Placebo
Breakdown of trials Prithviraj Bose has run
Myelofibrosis
Thrombocythemia
Essential Thrombocythemia
Primary Myelofibrosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Prithviraj Bose specialize in?
Prithviraj Bose focuses on Myelofibrosis and Thrombocythemia. In particular, much of their work with Myelofibrosis has involved JAK2 positive patients, or patients who are Stage I.
Is Prithviraj Bose currently recruiting for clinical trials?
Yes, Prithviraj Bose is currently recruiting for 2 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Prithviraj Bose has studied deeply?
Yes, Prithviraj Bose has studied treatments such as Ruxolitinib, Elotuzumab, CPI-0610.
What is the best way to schedule an appointment with Prithviraj Bose?
Apply for one of the trials that Prithviraj Bose is conducting.
What is the office address of Prithviraj Bose?
The office of Prithviraj Bose is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.